東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cancer Drug Screening Scale-Up: Comb...

Zhang, Zhixiong.

FindBook

Google Book

Amazon

博客來

Cancer Drug Screening Scale-Up: Combining Biomimetic Microfluidic Platforms and Deep Learning Image Analysis.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cancer Drug Screening Scale-Up: Combining Biomimetic Microfluidic Platforms and Deep Learning Image Analysis./
作者:	Zhang, Zhixiong.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
面頁冊數:	138 p.
附註:	Source: Dissertations Abstracts International, Volume: 82-07, Section: B.
Contained By:	Dissertations Abstracts International82-07B.
標題:	Cellular biology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28240367
ISBN:	9798684623042

Cancer Drug Screening Scale-Up: Combining Biomimetic Microfluidic Platforms and Deep Learning Image Analysis.
Zhang, Zhixiong.

Cancer Drug Screening Scale-Up: Combining Biomimetic Microfluidic Platforms and Deep Learning Image Analysis. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 138 p.

Source: Dissertations Abstracts International, Volume: 82-07, Section: B.

Thesis (Ph.D.)--University of Michigan, 2020.

This item must not be sold to any third party vendors.

The development of cancer drugs is usually costly and time-consuming, mainly due to growing complexity in screening large number of candidate compounds and high failure rates in translation from preclinical trials to clinical approval. Despite the great efforts, the preclinical screening platforms combing good clinical relevance and high throughput for large-scale drug testing is still lacking. In addition, accumulating evidence suggests that cancer drug response can be altered by tumor microenvironment (TME), which includes not only cancer cells but also physical, and biochemical cues in niches. To improve the current cancer drug screening assays, it is important to mimic local TME to achieve better physiological relevance. In the first part of this dissertation, three TME-mimicking microfluidic platforms were introduced for three different in-vitro TME-mimicking tumor sphere models: spheres in matrix, self-aggregated spheres, and single-cell clonal spheres. First, a 3D gel-island chip investigated the heterogeneity of single-cell drug responses in biomimetic extracellular matrix (ECM). With 1,500 isolated single cell chambers containing ECM, it was demonstrated that ECM support was favorable for some population of cancer cells to maintain stemness and develop drug resistance. This result suggested the importance of drug screening at single-cell resolution in TME-mimicking platforms. Secondly, a drug combination screening chip enabling high-throughput and scalable combinatorial drug screening was demonstrated for the aggregated sphere model. Instead of screening a single drug on each of the tumors, this chip allows the screening of all pairwise drug combinations from eight different cancer drugs, in total 172 different treatment conditions, and 1,032 tested samples in a single microfluidic chip. The presented design approach was easily scalable to incorporate arbitrary number of drugs for large-scale drug screening. Finally, single-cell Hi-Sphere chip enabled high-throughput clonal sphere culture and selective retrieval. Combining fluorescent dye on-situ staining techniques, we identified rare cancer stem-like cell population and confirms its location at the leading edge of spheres.Advance in experimental throughput generates massive data, which demands the corresponding automatic analysis and intelligent interpretation capabilities. The second part of this dissertation focuses on the applications of computer vision and machine learning algorithms to automated biomedical data processing. Image analysis with convolutional neural network was applied for drug efficacy evaluation in a fast and label-free manner. The estimated drug efficacy is highly correlated with the experimental ground truth (R-value > 0.93), while the predicted half-maximal inhibitory concentration is within 8% error range. In addition, metastatic fast-moving cells could be identified after extracting morphological features from the microscope images and applying deep learning algorithm for image analysis, achieving over 99% accuracy for cell movement direction prediction and 91% for speed prediction. In summary, this dissertation presents high-throughput TME-mimicking microfluidics and deep learning image analysis for large-scale drug screening solutions.

ISBN: 9798684623042Subjects--Topical Terms:

3172791
Cellular biology.
Subjects--Index Terms:

High throughput

Cancer Drug Screening Scale-Up: Combining Biomimetic Microfluidic Platforms and Deep Learning Image Analysis.
LDR:04848nmm a2200517 4500 001 2278441
005 20210628075028.5
008 220723s2020 ||||||||||||||||| ||eng d
020 $a 9798684623042
035 $a (MiAaPQ)AAI28240367
035 $a (MiAaPQ)umichrackham003401
035 $a AAI28240367
040 $a MiAaPQ $c MiAaPQ
100 1 $a Zhang, Zhixiong. $3 3556816
245 1 0 $a Cancer Drug Screening Scale-Up: Combining Biomimetic Microfluidic Platforms and Deep Learning Image Analysis.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 138 p.
500 $a Source: Dissertations Abstracts International, Volume: 82-07, Section: B.
500 $a Advisor: Yoon, Euisik.
502 $a Thesis (Ph.D.)--University of Michigan, 2020.
506 $a This item must not be sold to any third party vendors.
506 $a This item must not be added to any third party search indexes.
520 $a The development of cancer drugs is usually costly and time-consuming, mainly due to growing complexity in screening large number of candidate compounds and high failure rates in translation from preclinical trials to clinical approval. Despite the great efforts, the preclinical screening platforms combing good clinical relevance and high throughput for large-scale drug testing is still lacking. In addition, accumulating evidence suggests that cancer drug response can be altered by tumor microenvironment (TME), which includes not only cancer cells but also physical, and biochemical cues in niches. To improve the current cancer drug screening assays, it is important to mimic local TME to achieve better physiological relevance. In the first part of this dissertation, three TME-mimicking microfluidic platforms were introduced for three different in-vitro TME-mimicking tumor sphere models: spheres in matrix, self-aggregated spheres, and single-cell clonal spheres. First, a 3D gel-island chip investigated the heterogeneity of single-cell drug responses in biomimetic extracellular matrix (ECM). With 1,500 isolated single cell chambers containing ECM, it was demonstrated that ECM support was favorable for some population of cancer cells to maintain stemness and develop drug resistance. This result suggested the importance of drug screening at single-cell resolution in TME-mimicking platforms. Secondly, a drug combination screening chip enabling high-throughput and scalable combinatorial drug screening was demonstrated for the aggregated sphere model. Instead of screening a single drug on each of the tumors, this chip allows the screening of all pairwise drug combinations from eight different cancer drugs, in total 172 different treatment conditions, and 1,032 tested samples in a single microfluidic chip. The presented design approach was easily scalable to incorporate arbitrary number of drugs for large-scale drug screening. Finally, single-cell Hi-Sphere chip enabled high-throughput clonal sphere culture and selective retrieval. Combining fluorescent dye on-situ staining techniques, we identified rare cancer stem-like cell population and confirms its location at the leading edge of spheres.Advance in experimental throughput generates massive data, which demands the corresponding automatic analysis and intelligent interpretation capabilities. The second part of this dissertation focuses on the applications of computer vision and machine learning algorithms to automated biomedical data processing. Image analysis with convolutional neural network was applied for drug efficacy evaluation in a fast and label-free manner. The estimated drug efficacy is highly correlated with the experimental ground truth (R-value > 0.93), while the predicted half-maximal inhibitory concentration is within 8% error range. In addition, metastatic fast-moving cells could be identified after extracting morphological features from the microscope images and applying deep learning algorithm for image analysis, achieving over 99% accuracy for cell movement direction prediction and 91% for speed prediction. In summary, this dissertation presents high-throughput TME-mimicking microfluidics and deep learning image analysis for large-scale drug screening solutions.
590 $a School code: 0127.
650 4 $a Cellular biology. $3 3172791
650 4 $a Computer science. $3 523869
650 4 $a Biochemistry. $3 518028
650 4 $a Public health. $3 534748
650 4 $a Biomedical engineering. $3 535387
650 4 $a Oncology. $3 751006
650 4 $a Fluid mechanics. $3 528155
650 4 $a Electrical engineering. $3 649834
650 4 $a Morphology. $3 591167
653 $a High throughput
653 $a Microfluidics
653 $a Deep learning
653 $a Tumor microenvironment
653 $a Drug screening
653 $a Cancer cells
653 $a Cancer drugs
653 $a Cancer treatment
653 $a Drug combinations
690 $a 0544
690 $a 0541
690 $a 0984
690 $a 0287
690 $a 0573
690 $a 0379
690 $a 0992
690 $a 0487
690 $a 0204
710 2 $a University of Michigan. $b Electrical Engineering. $3 2093655
773 0 $t Dissertations Abstracts International $g 82-07B.
790 $a 0127
791 $a Ph.D.
792 $a 2020
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28240367